Elucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsule

World Journal of Gastroenterology

Volumn 22, Issue 38, 2016, Pages 8489-8496

  Liu, Qiushi ^a   Somiya, Masaharu ^a   Kuroda, Shun'ichi ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Bio nanocapsule; Endosomal escape; Heparan sulfate proteoglycan; Hepatitis B virus; Sodium taurocholate cotransporting polypeptide

Indexed keywords

BIONANOCAPSULE; LIPOSOME; NANOCAPSULE; PROTEOHEPARAN SULFATE; SODIUM BILE ACID COTRANSPORTER; UNCLASSIFIED DRUG; VITRONECTIN; COTRANSPORTER; ORGANIC ANION TRANSPORTER; S ENVELOPE PROTEIN, HEPATITIS B VIRUS; SODIUM-BILE ACID COTRANSPORTER; VIRUS ENVELOPE PROTEIN;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; ENDOCYTOSIS; ENDOSOME; ENZYME INHIBITION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LIVER CELL; NANOENCAPSULATION; NONHUMAN; PH; REVIEW; SACCHAROMYCES CEREVISIAE; VIRUS CELL INTERACTION; VIRUS UNCOATING; ANIMAL; CHEMISTRY; GENETICS; LIVER; MEMBRANE FUSION; METABOLISM; MOUSE; PROTEIN DOMAIN; VIROLOGY;

ANIMALS; ENDOCYTOSIS; ENDOSOMES; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER; MEMBRANE FUSION; MICE; NANOCAPSULES; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; PROTEIN DOMAINS; SYMPORTERS; VIRAL ENVELOPE PROTEINS;

EID: 84991080532     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i38.8489     Document Type: Review

References (49)

1. Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985; 317: 489-495 [PMID: 2995835 DOI: 10.1038/317489a0]
2. Walter E, Keist R, Niederöst B, Pult I, Blum HE. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 1996; 24: 1-5 [PMID: 8707245 DOI: 10.1002/hep.510240101]
3. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, Guyomard C, Lucas J, Trepo C, Guguen-Guillouzo C. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci USA 2002; 99: 15655-15660 [PMID: 12432097 DOI: 10.1073/ pnas.232137699]
4. Neurath AR, Kent SB, Strick N, Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 1986; 46: 429-436 [PMID: 3015414 DOI: 10.1016/00 92-8674(86)90663-X]
5. Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH. Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol 1984; 52: 396-402 [PMID: 6492255]
6. Glebe D, Aliakbari M, Krass P, Knoop EV, Valerius KP, Gerlich WH. Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J Virol 2003; 77: 9511-9521 [PMID: 12915565 DOI: 10.1128/JVI.77.17.9511-9521.2003]
7. Gripon P, Le Seyec J, Rumin S, Guguen-Guillouzo C. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 1995; 213: 292-299 [PMID: 7491754 DOI: 10.1006/viro.1995.0002]
8. Schulze A, Gripon P, Urban S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 2007; 46: 1759-1768 [PMID: 18046710 DOI: 10.1002/hep.21896]
9. Leistner CM, Gruen-Bernhard S, Glebe D. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell Microbiol 2008; 10: 122-133 [PMID: 18086046 DOI: 10.1111/j.1462-5822.2007.01023.x]
10. Abou-Jaoudé G, Sureau C. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange. J Virol 2007; 81: 13057-13066 [PMID: 17898062 DOI: 10.1128/JVI.01495-07]
11. Salisse J, Sureau C. A function essential to viral entry underlies the hepatitis B virus "a" determinant. J Virol 2009; 83: 9321-9328 [PMID: 19570861 DOI: 10.1128/JVI.00678-09]
12. Sureau C, Salisse J. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology 2013; 57: 985-994 [PMID: 23161433 DOI: 10.1002/hep.26125]
13. Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68: 729-777 [PMID: 10872465 DOI: 10.1146/annurev.biochem.68.1.729]
14. Engelman A, Cherepanov P. The structural biology of HIV-1: mechanistic and therapeutic insights. Nat Rev Microbiol 2012; 10: 279-290 [PMID: 22421880 DOI: 10.1038/nrmicro2747]
15. Hagenbuch B, Meier PJ. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/ bile acid cotransporter. J Clin Invest 1994; 93: 1326-1331 [PMID: 8132774 DOI: 10.1172/JCI117091]
16. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 2012; 1: e00049 [PMID: 23150796 DOI: 10.7554/ eLife.00049]
17. Döring B, Lütteke T, Geyer J, Petzinger E. The SLC10 carrier family: transport functions and molecular structure. Curr Top Membr 2012; 70: 105-168 [PMID: 23177985 DOI: 10.1016/B978-0-12-394316-3.00004-1]
18. Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Fälth M, Stindt J, Königer C, Nassal M, Kubitz R, Sültmann H, Urban S. Hepatitis B and D viruses exploit sodium taurocholate cotransporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 2014; 146: 1070-1083 [PMID: 24361467 DOI: 10.1053/j.gastro.2013.12.024]
19. Urban S, Bartenschlager R, Kubitz R, Zoulim F. Strategies to inhibit entry of HBV and HDV into hepatocytes. Gastroenterology 2014; 147: 48-64 [PMID: 24768844 DOI: 10.1053/j.gastro.2014.04.030]
20. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 1982; 298: 347-350 [PMID: 7045698 DOI: 10.1038/298347a0]
21. Clemens R, Sänger R, Kruppenbacher J, Höbel W, Stanbury W, Bock HL, Jilg W. Booster immunization of low-and nonresponders after a standard three dose hepatitis B vaccine schedule-results of a post-marketing surveillance. Vaccine 1997; 15: 349-352 [PMID: 9141203 DOI: 10.1016/S0264-410X(96)00205-8]
22. Itoh Y, Takai E, Ohnuma H, Kitajima K, Tsuda F, Machida A, Mishiro S, Nakamura T, Miyakawa Y, Mayumi M. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci USA 1986; 83: 9174-9178 [PMID: 3466181]
23. Kuroda S, Fujisawa Y, Iino S, Akahane Y, Suzuki H. Induction of protection level of anti-pre-S2 antibodies in humans immunized with a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine). Vaccine 1991; 9: 163-169 [PMID: 1828318 DOI: 10.1016/0264-410X(91)90148-Y]
24. Kuroda S, Otaka S, Miyazaki T, Nakao M, Fujisawa Y. Hepatitis B virus envelope L protein particles. Synthesis and assembly in Saccharomyces cerevisiae, purification and characterization. J Biol Chem 1992; 267: 1953-1961 [PMID: 1370486]
25. Jung J, Iijima M, Yoshimoto N, Sasaki M, Niimi T, Tatematsu K, Jeong SY, Choi EK, Tanizawa K, Kuroda S. Efficient and rapid purification of drug-and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiae. Protein Expr Purif 2011; 78: 149-155 [PMID: 21515381 DOI: 10.1016/j.pep.2011.04.008]
26. Yamada T, Iwabuki H, Kanno T, Tanaka H, Kawai T, Fukuda H, Kondo A, Seno M, Tanizawa K, Kuroda S. Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein. Vaccine 2001; 19: 3154-3163 [PMID: 11312011 DOI: 10.1016/S0264-410X(01)00017-2]
27. Bruss V. Hepatitis B virus morphogenesis. World J Gastroenterol 2007; 13: 65-73 [PMID: 17206755 DOI: 10.3748/wjg.v13.i1.65]
28. Jung J, Matsuzaki T, Tatematsu K, Okajima T, Tanizawa K, Kuroda S. Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials. J Control Release 2008; 126: 255-264 [PMID: 18207275 DOI: 10.1016/j.jconrel.2007.12.002]
29. Bremer CM, Bung C, Kott N, Hardt M, Glebe D. Hepatitis B virus infection is dependent on cholesterol in the viral envelope. Cell Microbiol 2009; 11: 249-260 [PMID: 19016777 DOI: 10.1111/ j.1462-5822.2008.01250.x]
30. Somiya M, Kuroda S. Development of a virus-mimicking nanocarrier for drug delivery systems: The bio-nanocapsule. Adv Drug Deliv Rev 2015; 95: 77-89 [PMID: 26482188 DOI: 10.1016/ j.addr.2015.10.003]
31. Kasuya T, Jung J, Kinoshita R, Goh Y, Matsuzaki T, Iijima M, Yoshimoto N, Tanizawa K, Kuroda S. Chapter 8-Bionanocapsule-liposome conjugates for in vivo pinpoint drug and gene delivery. Methods Enzymol 2009; 464: 147-166 [PMID: 19903554 DOI: 10.1016/S0076-6879(09)64008-8]
32. Yamada T, Iwasaki Y, Tada H, Iwabuki H, Chuah MK, VandenDriessche T, Fukuda H, Kondo A, Ueda M, Seno M, Tanizawa K, Kuroda S. Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nat Biotechnol 2003; 21: 885-890 [PMID: 12833071 DOI: 10.1038/nbt843]
33. Matsuura Y, Yagi H, Matsuda S, Itano O, Aiura K, Kuroda S, Ueda M, Kitagawa Y. Human liver-specific nanocarrier in a novel mouse xenograft model bearing noncancerous human liver tissue. Eur Surg Res 2011; 46: 65-72 [PMID: 21178358 DOI: 10.1159/000322491]
34. Liu Q, Jung J, Somiya M, Iijima M, Yoshimoto N, Niimi T, Maturana AD, Shin SH, Jeong SY, Choi EK, Kuroda S. Virosomes of hepatitis B virus envelope L proteins containing doxorubicin: synergistic enhancement of human liver-specific antitumor growth activity by radiotherapy. Int J Nanomedicine 2015; 10: 4159-4172 [PMID: 26203243 DOI: 10.2147/IJN.S84295]
35. Krone B, Lenz A, Heermann KH, Seifer M, Lu XY, Gerlich WH. Interaction between hepatitis B surface proteins and monomeric human serum albumin. Hepatology 1990; 11: 1050-1056 [PMID: 2163967 DOI: 10.1002/hep.1840110622]
36. Ishihara K, Waters JA, Pignatelli M, Thomas HC. Characterisation of the polymerised and monomeric human serum albumin binding sites on hepatitis B surface antigen. J Med Virol 1987; 21: 89-95 [PMID: 3794674 DOI: 10.1002/jmv.1890210112]
37. Itoh Y, Kuroda S, Miyazaki T, Otaka S, Fujisawa Y. Identification of polymerized-albumin receptor domain in the pre-S2 region of hepatitis B virus surface antigen M protein. J Biotechnol 1992; 23: 71-82 [PMID: 1369362 DOI: 10.1016/0168-1656(92)90100-N]
38. Kasuya T, Nomura S, Matsuzaki T, Jung J, Yamada T, Tatematsu K, Okajima T, Tanizawa K, Kuroda S. Expression of squamous cell carcinoma antigen-1 in liver enhances the uptake of hepatitis B virus envelope-derived bio-nanocapsules in transgenic rats. FEBS J 2008; 275: 5714-5724 [PMID: 18959756 DOI: 10.1111/ j.1742-4658.2008.06698.x]
39. Yamada M, Oeda A, Jung J, Iijima M, Yoshimoto N, Niimi T, Jeong SY, Choi EK, Tanizawa K, Kuroda S. Hepatitis B virus envelope L protein-derived bio-nanocapsules: mechanisms of cellular attachment and entry into human hepatic cells. J Control Release 2012; 160: 322-329 [PMID: 22100387 DOI: 10.1016/ j.jconrel.2011.11.004]
40. Meier A, Mehrle S, Weiss TS, Mier W, Urban S. Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes. Hepatology 2013; 58: 31-42 [PMID: 23213046 DOI: 10.1002/hep.26181]
41. Somiya M, Liu Q, Yoshimoto N, Iijima M, Tatematsu K, Nakai T, Okajima T, Kuroki K, Ueda K, Kuroda S. Cellular uptake of hepatitis B virus envelope L particles is independent of sodium taurocholate cotransporting polypeptide, but dependent on heparan sulfate proteoglycan. Virology 2016; 497: 23-32 [PMID: 27420796 DOI: 10.1016/j.virol.2016.06.024]
42. Smith AE, Helenius A. How viruses enter animal cells. Science 2004; 304: 237-242 [PMID: 15073366 DOI: 10.1126/ science.1094823]
43. Baumert TF, Meredith L, Ni Y, Felmlee DJ, McKeating JA, Urban S. Entry of hepatitis B and C viruses-recent progress and future impact. Curr Opin Virol 2014; 4: 58-65 [PMID: 24418809 DOI: 10.1016/j.coviro.2013.12.002]
44. Oess S, Hildt E. Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens. Gene Ther 2000; 7: 750-758 [PMID: 10822301 DOI: 10.1038/sj.gt.3301154]
45. Rodríguez-Crespo I, Gómez-Gutiérrez J, Nieto M, Peterson DL, Gavilanes F. Prediction of a putative fusion peptide in the S protein of hepatitis B virus. J Gen Virol 1994; 75: 637-639 [PMID: 8126460 DOI: 10.1099/0022-1317-75-3-637]
46. Delgado CL, Núñez E, Yélamos B, Gómez-Gutiérrez J, Peterson DL, Gavilanes F. Study of the putative fusion regions of the preS domain of hepatitis B virus. Biochim Biophys Acta 2015; 1848: 895-906 [PMID: 25554595 DOI: 10.1016/j.bbamem.2014.12.020]
47. Somiya M, Sasaki Y, Matsuzaki T, Liu Q, Iijima M, Yoshimoto N, Niimi T, Maturana AD, Kuroda S. Intracellular trafficking of bio-nanocapsule-liposome complex: Identification of fusogenic activity in the pre-S1 region of hepatitis B virus surface antigen L protein. J Control Release 2015; 212: 10-18 [PMID: 26074149 DOI: 10.1016/j.jconrel.2015.06.012]
48. Watashi K, Wakita T. Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue Tropism. Cold Spring Harb Perspect Med 2015; 5: a021378 [PMID: 26238794 DOI: 10.1101/ cshperspect.a021378]
49. Liu Q, Somiya M, Shimada N, Sakamoto W, Yoshimoto N, Iijima M, Tatematsu K, Nakai T, Okajima T, Maruyama A, Kuroda S. Mutational analysis of hepatitis B virus pre-S1 (9-24) fusogenic peptide. Biochem Biophys Res Commun 2016; 474: 406-412 [PMID: 27120459 DOI: 10.1016/j.bbrc.2016.04.125]